123 related articles for article (PubMed ID: 1966393)
1. Inhibition of antigen presentation in vitro and in vivo by MHC antagonist peptides.
Lamont AG; Sette A; Grey HM
Int Rev Immunol; 1990; 6(1):49-59. PubMed ID: 1966393
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules.
Lamont AG; Sette A; Fujinami R; Colón SM; Miles C; Grey HM
J Immunol; 1990 Sep; 145(6):1687-93. PubMed ID: 1697306
[TBL] [Abstract][Full Text] [Related]
3. The use of peptide analogs with improved stability and MHC binding capacity to inhibit antigen presentation in vitro and in vivo.
Lamont AG; Powell MF; Colón SM; Miles C; Grey HM; Sette A
J Immunol; 1990 Apr; 144(7):2493-8. PubMed ID: 2319129
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of entire myelin basic protein-induced experimental autoimmune encephalomyelitis in Lewis rats by major histocompatibility complex class II-binding competitor peptides.
Wauben MH; Kozhich A; Joosten I; Schlief A; Boog CJ; van Eden W
Eur J Immunol; 1994 May; 24(5):1053-60. PubMed ID: 7514128
[TBL] [Abstract][Full Text] [Related]
5. Self and non-self peptides treat autoimmune encephalomyelitis: T cell anergy or competition for major histocompatibility complex class II binding?
Gautam AM
Eur J Immunol; 1995 Jul; 25(7):2059-63. PubMed ID: 7542603
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide.
Wauben MH; Joosten I; Schlief A; van der Zee R; Boog CJ; van Eden W
J Immunol; 1994 Apr; 152(8):4211-20. PubMed ID: 7511673
[TBL] [Abstract][Full Text] [Related]
7. Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides.
Ishioka GY; Adorini L; Guery JC; Gaeta FC; LaFond R; Alexander J; Powell MF; Sette A; Grey HM
J Immunol; 1994 May; 152(9):4310-9. PubMed ID: 8157954
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of experimental autoimmune encephalomyelitis by a nonimmunogenic non-self peptide that binds to I-Au.
Gautam AM; Pearson CI; Sinha AA; Smilek DE; Steinman L; McDevitt HO
J Immunol; 1992 May; 148(10):3049-54. PubMed ID: 1578131
[TBL] [Abstract][Full Text] [Related]
9. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.
Meyer zu Hörste G; Heidenreich H; Mausberg AK; Lehmann HC; ten Asbroek AL; Saavedra JT; Baas F; Hartung HP; Wiendl H; Kieseier BC
Neurobiol Dis; 2010 Feb; 37(2):483-90. PubMed ID: 19914379
[TBL] [Abstract][Full Text] [Related]
10. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
[TBL] [Abstract][Full Text] [Related]
11. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
Agrawal B; Manickasundari M; Fraga E; Singh B
J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
[TBL] [Abstract][Full Text] [Related]
12. Utility of azapeptides as major histocompatibility complex class II protein ligands for T-cell activation.
Hart M; Beeson C
J Med Chem; 2001 Oct; 44(22):3700-9. PubMed ID: 11606135
[TBL] [Abstract][Full Text] [Related]
13. Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins.
Sakai K; Zamvil SS; Mitchell DJ; Hodgkinson S; Rothbard JB; Steinman L
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9470-4. PubMed ID: 2480602
[TBL] [Abstract][Full Text] [Related]
14. Nature of the ligand recognized by a hapten- and carrier-specific, MHC-restricted T cell receptor.
Nalefski EA; Rao A
J Immunol; 1993 May; 150(9):3806-16. PubMed ID: 7682584
[TBL] [Abstract][Full Text] [Related]
15. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Weissert R; de Graaf KL; Storch MK; Barth S; Linington C; Lassmann H; Olsson T
J Immunol; 2001 Jun; 166(12):7588-99. PubMed ID: 11390515
[TBL] [Abstract][Full Text] [Related]
16. Selective immunosuppression by administration of major histocompatibility complex class II-binding peptides. II. Preventive inhibition of primary and secondary in vivo antibody responses.
Guéry JC; Neagu M; Rodriguez-Tarduchy G; Adorini L
J Exp Med; 1993 May; 177(5):1461-8. PubMed ID: 8478615
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity.
Metzler B; Wraith DC
Int Immunol; 1993 Sep; 5(9):1159-65. PubMed ID: 7694644
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune response.
Wauben MH; Hoedemaekers AC; Graus YM; Wagenaar JP; van Eden W; de Baets MH
Eur J Immunol; 1996 Dec; 26(12):2866-75. PubMed ID: 8977279
[TBL] [Abstract][Full Text] [Related]
19. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
McMenamin C; Holt PG
J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of superantigen recognition by peptides of the variable region of the T cell receptor beta chain.
MacNeil D; Fraga E; Singh B
Eur J Immunol; 1992 Apr; 22(4):937-41. PubMed ID: 1532364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
